Agent fibrinolytique

Patent europeic · EP0225286 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP0225286
Numer da la dumonda
EP86810518
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
13-11-1986
Publitgà
10-06-1987
Concedì
22-07-1992
Stritgà
30-11-2005
Motiv
Taxa annuala betg pajada
Classas IPC
C12N 15/58 (2006.01)
C12N 9/64 (2006.01)
C12N 1/19 (2006.01)
A61K 37/54 (1990.01)
Prioritad
GB A 8528321 18.11.1985
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 14-07-2006

    Stritgà, taxa betg pajada

    Published in +pat+ No 13 in 2006

  2. 14-02-1997

    Adressa midada

    Owner
    CIBA-GEIGY AG, Klybeckstrasse 141, 4002 Basel → Novartis AG, Schwarzwaldallee 215, 4058 Basel

    Published in PIDTJ No 3 in 1997

  3. 31-08-1992

    Concedì

    Published in PIDTJ No 16 in 1992

Partidas

Possessur

Novartis AG

Schwarzwaldallee 215, 4058 Basel

Inventur

Chaudhuri, Bhabatosh, Dr.

CH-4058 Basel

Meyhack, Bernd, Dr.

CH-4312 Magden

Heim, Jutta, Dr.

CH-4133 Pratteln

Van Oostrum, Jan, Dr.

CH-4142 Münchenstein

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.